News Archive

The observational study found that amongst acute ischemic stroke patients treated with intravenous tissue plasminogen activator, patients who had experienced a previous stroke within the past two w

The HARMONEE trial is part of the Harmonization by Doing program, which aims to create a uniform pathway for clinical development in the U.S. and Japan.

A new analysis from the DCRI showed that 35 percent of direct costs related to musculoskeletal pain were attributable to about 4 percent of patients who were persistent high-cost utilizers.

The initiative, which will be led by a DCRI pediatrician, aims to create a new care and services model for children in five North Carolina counties.

As the year—and the decade—draws to a close, we take a look back at some of our accomplishments and the ways in which we shared knowledge in 2019.

The survey focused on invasive cardiac care and measured patient knowledge, goals, and concerns related to these procedures.

A study showed that young adults with ADHD were more likely to self-administer nicotine in both relaxing and cognitively difficult scenarios.

The Antibacterial Resistance Leadership Group conducts clinical research to better understand how to diagnose, treat, and prevent antibacterial resistant infections.

With eight-plus clinical areas under one roof, the DCRI enables faculty members of various specialties to work together to draw deeper insights in clinical research and find better treatments for patients.

In a recent editorial in Circulation, the DCRI’s Michael Felker, MD, raises questions that the heart failure field should consider in light of new results from the DAPA-HF trial.